Skip to main content
SpringerLink
Log in
Book cover

Cachexia and Wasting: A Modern Approach pp 163–171Cite as

Non-AIDS Lipodystrophy Syndrome

  • Chapter

  • 2110 Accesses

Abstract

Lipodystrophies (LDs) are clinically heterogeneous acquired or inherited disorders characterised by a generalised or regional loss of adipose tissue. Generalised LDs, both inherited and acquired, are associated with peripheral insulin resistance, glucose intolerance or overt diabetes, acanthosis nigricans, dyslipidaemia. Bone demineralisation and polycystic ovary syndrome are also part of these diseases. LDs can be classified as acquired or congenital, and generalised or partial (Table 1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lawrence RD (1946) Lipodystrophy and hepatomegaly with diabetes, lipemia and other metabolic disturbances. Lancet 1:724–731

    Article  Google Scholar 

  2. Misra A, Garg A (2003) Clinical features and metabolic derangements in acquired generalized lipodistrophy: case reports and review of the literature. Medicine 82:129–146

    Article  PubMed  Google Scholar 

  3. Garg A (2000) Lipodistrophies. Am J Med 108:143–152

    Article  PubMed  CAS  Google Scholar 

  4. Huemer C, Kitson H, Realleson PN et al (2001) Lipodystrophy in patients with juvenile dermatomyositis. Evaluation of clinical and metabolic abnormalities. J Rheumatol 28:610–615

    PubMed  CAS  Google Scholar 

  5. Billings JK, Milgraum SS, Gupta AK et al (1987) Lipoatrophic panniculitis: a possible autoimmune inflammatory disease of fat: report of three cases. Arch Dermatol 123:1662–1666

    Article  PubMed  CAS  Google Scholar 

  6. Hacque WA, Shimomura I, Matsuzawa Y, Garg A (2002) Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87:2395–2398

    Article  Google Scholar 

  7. Mitchell SW(1885) Singular case of absence of adipose matter in the upper half of the body. Am J Med Sci 90:105–106

    Google Scholar 

  8. Barraquer L (1907) Histoire clinique d’un cas d’atrophie du tissue celluloadipeux. Neurolog Centralblatt 26:1072

    Google Scholar 

  9. Simons A (1911) Eine seltnen throphoneurose (‘Lipodystrophia progressiva’). Z Gesamte Neurol Psychiatr 5:29–38

    Google Scholar 

  10. Eisinger AJ, Shortland JR, Moorhead PJ (1972) Renal disease in partial lipodostrophy. QJ Med 41:343–354

    CAS  Google Scholar 

  11. Peters DK, Charlesworth JA, Sissons JG et al (1973) Mesangiocapillary nephritis, partial lipodystrophy and hypocomplementaemia. Lancet 2:538–539

    Google Scholar 

  12. Williams DG, Bartlett A, Duffus P (1978) Identification of nephritic factor as an immunoglobulin. Clin Exp Immunol 33:425–429

    PubMed  CAS  Google Scholar 

  13. Wrst CD, McAdams AJ(1999) The alternative pathway C3 convertase and glomerular deposits. Pediatr Nephrol 13:448–453

    Article  Google Scholar 

  14. Mathieson PW, Wurzner R, Oliveria DB et al (1993) Complement-mediated adipocyte lysis by nephritic factor sera. J Exp Med 177:1827–1831

    Article  PubMed  CAS  Google Scholar 

  15. Walport MJ, Davies KA, Botto M et al (1994) C3 nephritic factor, and SLE: report of four cases and review of the literature. QJ Med 87:609–615

    CAS  Google Scholar 

  16. Font J, Herrero C, Bosch X et al(1990) Systematic lupus erythematosus in a patient with partial lipodystrophy. J Am Acad Dermatol 22:337–340

    PubMed  CAS  Google Scholar 

  17. Cronin CC, Higgins T, Mollory M (1995) Lupus, C3 nephritic factor and partial lipodystrophy. QJ Med 88:298–299

    CAS  Google Scholar 

  18. Torrelo A, Espana A, Boixeda P, Ledo A (1991) Partial lipodistrophy and dermatomyositis. Arch Dermatol 127:1846–1847

    Article  PubMed  CAS  Google Scholar 

  19. Atlan Gepner C, Bongrand P, Fornasier C et al (1996) Insulin induced lipoatrophy in type I diabetes. A possible tumor necrosis factor alpha-mediated differentiation of adipocytes. Diabetes Care 19:1283–1285

    Article  PubMed  CAS  Google Scholar 

  20. Imamura S, Yamada M, Yamamoto K (1984) Lipodystrophya centrifugalis abdominalis infantilis. A follow-up study. J Am Acad Dermatol 11:203–209

    PubMed  CAS  Google Scholar 

  21. Berardinelli W (1954) An undiagnosed endocrinometabolic syndrome report of 2 cases. J Clin Endocrinol Metab 14:193–204

    Article  PubMed  CAS  Google Scholar 

  22. Scip M (1959) Lipodistrophy and gigantism with associated endocrine manifestation: a new diencephalic syndrome? Acta Paediatr 48:555–574

    Google Scholar 

  23. Seip M, Trygstad O (1996) Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr 413:2–28

    CAS  Google Scholar 

  24. Garg A, Flecknstein JL, Peshork RM, Grundy SM (1992) Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J Clin Endocrinol Metab 75:358–361

    Article  PubMed  CAS  Google Scholar 

  25. Enzi G, Cominacini L, Dodi G et al (1988) Lipid metabolism in lipoatrophic diabetes. Horm Metabol Res 20:587–591

    Article  CAS  Google Scholar 

  26. Agarwal AK, Arioglu A, de Almeida S et al (2002) AGPA2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31:21–23

    Article  PubMed  CAS  Google Scholar 

  27. Agarwal AK, Simha V, Oral EA et al (2003) Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 88:4840–4847

    Article  PubMed  CAS  Google Scholar 

  28. Simha V, Garg A (2003) Phenotypic heterogeneity in body fat distribution in patient with congenital generalized lipodystrophy caused by mutation in the AGPAT2 or Scipin genes. J Clin Endocrinol Metab 88:5433–5437

    Article  PubMed  CAS  Google Scholar 

  29. Van Maldergem L, Magre J, Khallonf E et al (2003) Genotype-phenotype relationships in Berardinelli-Scip congenital lipodystrophy. J Med Genet 40:150

    Article  Google Scholar 

  30. Magre J, Delpine M, Khallonf E et al (2001) Identification of the gene altered in Berardinelli-Scip congenital lipodystrophy on chromosome 1 Iql3. Nat Genet 28:365–370

    Article  PubMed  CAS  Google Scholar 

  31. Garg A, Wilson R, Barnes R et al (1994) A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 84:3390–3394

    Article  Google Scholar 

  32. Dunningam MG, Cochrane MA, Kelly A, Scott JW (1974) Familial lipoatrophic diabetes with dominant transmission: a new syndrome. QJ Med 49:33–48

    Google Scholar 

  33. Peters JM, Bannes R, Bennet L et al (1998) Localization of the gene for familial partial lipodystrophy (Dunningan variety) to chromosome Iq21-22. Nature Genet 18:292–295

    Article  PubMed  CAS  Google Scholar 

  34. Kobberling J, Willms B, Katterman R, Creutzfeld W (1975) Lipodystrophy of the extremities. A dominant inherited syndrome associated with lipoatrophyc diabetes. Humangenetik 29:111–120

    Article  PubMed  CAS  Google Scholar 

  35. Agarwal AK, Garg A (2002) A novel heterozygous mutation in perixosome proliferators activated receptorgamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 87:418–419

    Article  Google Scholar 

  36. Barroso I, Gurnell M, Crowley VE et al (1999) Dominant negative mutation in human PPAR-gamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402:880–883

    PubMed  CAS  Google Scholar 

  37. Garg A, Vinaitherthan M, Weatherale PT, Boncork AM (2001) Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunningan variety) related to the site of missense mutation in lamin A/C gene. J Clin Endocrinol Metab 86:59–65

    Article  PubMed  CAS  Google Scholar 

  38. Young LW, Radebaugh JF, Rubin P et al (1971) New syndrome manifested by mandibular hypoplasia, acroosteolysis, still joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys. Birth defects 7:291–297

    PubMed  CAS  Google Scholar 

  39. Simba V, Garg A (2002) Bodyfat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia. J Clin Endocrinol Metab 87:776–785

    Article  Google Scholar 

  40. Novelli G, Munchir A, Sangiuolo F et al (2002) Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 71:426–431

    Article  PubMed  CAS  Google Scholar 

  41. Agarwal AK, Fryns JP, Auchus RJ, Garg A (2003) Zinc metalloproteinase ZMPSTE 24 is mutated in mandibuloacral dysplasia. Hum Mol Genet 12:1995–2001

    Article  PubMed  CAS  Google Scholar 

  42. Sensenbrenner JA, Hussels IE, Levin LS (1975) A low birth weight syndrome, Riegen syndrome? Birth Defects Orig Artic Ser 11:423–426

    PubMed  CAS  Google Scholar 

  43. Pivnick EK, Angle B, Kaufman RA et al (2000) 0Neonatal progeroid (Wiedemann-Rautenstrauch) syndrome: report of five new cases and review. Am J Med Genet 90:131–140

    Article  PubMed  CAS  Google Scholar 

  44. Caux F, Dubosclard E, Lascols O et al (2003) A new clinical condition linked to a novel mutation in lamin A and C with generalized lipodystrophy, insulin resistant diabetes, disseminated leukomelanodermic papules, liver steatosis and cardiomyopathy. J Clin Endocrinol Metab 88:1006–1013

    Article  PubMed  CAS  Google Scholar 

  45. Busetto L, Sträter D, Enzi G et al (2003) Differential clinical expression of multiple symmetric lipomatosis in men and women. Int J Obesity 27:1419–1422

    Article  CAS  Google Scholar 

  46. Zancanaro C, Sbarbati A, Morrini M et al (1990) Multiple symmetric lipomatosis. Ultrastructural investigation of the tissue and preadipocytes in primary culture. Lab Invest 63:253–258

    PubMed  CAS  Google Scholar 

  47. Cinti S, Enzi G, Cigolini M, Bosello O (1983) Ultrastructural features of cultured mature adipocyte precursors from adipose tissue in multiple symmetric lipomatosis. Ultrastruct Pathol 5:145–152

    PubMed  CAS  Google Scholar 

  48. Enzi G, Busetto L, Ceschin E et al (2002) Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study. Int J Obesity 26:253–261

    Article  CAS  Google Scholar 

  49. Enzi G, Angelini C, Negrin P et al (1986) Sensory, motor and autonomie neuropathy in patients with multiple symmetric lipomatosis. Medicine 64:388–393

    Google Scholar 

  50. Enzi G, Dorigo P, Prosdocimi M et al (1977) Multiple symmetric lipomatosis: a defect in adrenergic stimulated lipolysis. J Clin Invest 60:1221–1229

    Article  PubMed  CAS  Google Scholar 

  51. Enzi G, Martini S, Baggio G et al (1985) Lipoprotein metabolism in patients with elevated lipoproteinlipase activity in adipose tissue. Int J Obesity 9:173–176

    Google Scholar 

  52. Coin A, Enzi G, Bussolotto M et al (2000) Multiple symmetric lipomatosis: evidence for mitochondrial dysfunction. J Clin Neuromusc Dis 1:124–130

    Article  CAS  Google Scholar 

  53. Nisoli E, Regianini L, Briscini L et al(2002) Multiple symmetric lipomatosis may be the consequence of detective noradrenergic modulation of proliferation of brown fat cells. J Pathol 198:378–387

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, Geriatrics Division, University of Padua, Padua, Italy

    Giuliano Enzi, Luca Busetto, Giuseppe Sergi & Sabrina Pigozzo

Authors
  1. Giuliano Enzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Busetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Sergi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sabrina Pigozzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, University of Cagliari, Cagliari, Italy

    Giovanni Mantovani

  2. Department of Clinical Cardiology, Imperial College, NHLI, London, UK

    Stefan D. Anker

  3. Department of Cardiology Charité, Applied Cachexia Research, Campus Virchow-Klinikum, Berlin, Germany

    Stefan D. Anker

  4. Department of Behavioral Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    Akio Inui

  5. GRECC, VA Medical Center and Division of Geriatric Medicine, Saint Louis University, St. Louis, MO, USA

    John E. Morley

  6. Department of Clinical Medicine, University of Rome, La Sapienza, Rome, Italy

    Filippo Rossi Fanelli

  7. Department of Infectious Diseases, IRCCS S.Matteo Polyclinic, University of Pavia, Pavia, Italy

    Daniele Scevola

  8. Bone Marrow and Blood Stem Cell Transplantation Program, Center for Lymphoma and Myeloma, New York Presbyterian Hospital/Weill Medical Center, New York, NY, USA

    Michael W. Schuster

  9. Department of Medicine-Geriatrics, University of New York at Stony Brook VAMC, Northport, NY, USA

    Shing-Shing Yeh

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Enzi, G., Busetto, L., Sergi, G., Pigozzo, S. (2006). Non-AIDS Lipodystrophy Syndrome. In: Mantovani, G., et al. Cachexia and Wasting: A Modern Approach. Springer, Milano. https://doi.org/10.1007/978-88-470-0552-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0552-5_16

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0471-9

  • Online ISBN: 978-88-470-0552-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation